A Phase II study of Gefitinib in Patients with Advanced Salivary Gland Cancers

By John A Jakob, M. Kies, B. Glisson, M. Kupferman, Diane D. Liu, J. J. Lee, Adel K. El-Naggar, A. González-Angulo, George R Blumenschein. 2015

Subfields: Oncology, Otorhinolaryngology, Pharmacology